Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer's disease.

Pharmacogenomics - 1 Jan 2025

Kanda Anmol, Rani Anjna, Mazumder Avijit

Abstract excerpt

Alzheimer's Disease (AD) represents a formidable challenge in neurology, characterized by progressive neurodegeneration and cognitive decline. Traditional therapeutic approaches have failed to deliver significant outcomes, underscoring the need for innovative paradigms such as precision medicine. The review explores integrating genomic, biomarker-driven, and individualized therapeutic strategies to tackle AD. It...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to APOE gene

Share to MTHFR gene

Share to Genetic Predisposition to Disease

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 40952411
DOI: 10.1080/14622416.2025.2560296
PMCID: PMC12582071

Genes

APOE
MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer's disease.PMID 40952411Read ↗

Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled TrialSemantic proximity Read ↗

Genomic Insights into Dementia: Precision Medicine and the Impact of Gene-Environment Interaction.Semantic proximity Read ↗

Recent Progress in Alzheimer’s Disease Research, Part 2: Genetics and EpidemiologySemantic proximity Read ↗

Precision medicine of frontotemporal dementia: from genotype to phenotype.Semantic proximity Read ↗

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.Semantic proximity Read ↗

The molecular etiology of Alzheimer's disease.Semantic proximity Read ↗

Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.Semantic proximity Read ↗

Precision Medicine: Clarity for the Complexity of Dementia.Semantic proximity Read ↗

Integrating Genetic and Immune Profiles for Personalized Immunotherapy in Alzheimer’s DiseaseSemantic proximity Read ↗

Genetics of Alzheimer’s diseaseSemantic proximity Read ↗

Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled TrialSemantic proximity Read ↗

Alzheimer's disease genetics: from the bench to the clinic.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.